Supplementary Table S1 from A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant <i>TP53</i> and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years
Supplementary Table S1 from A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years
Zeina Al‐Mansour, Uma Borate, Daelynn R. Buelow, Alice S. Mims et al.
Topics
Acute Myeloid Leukemia Research
article
Supplementary Table S1 from A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years
Zeina Al‐Mansour, Uma Borate, Daelynn R. Buelow, Alice S. Mims, Ross L. Levine, Matthew C. Foster, Ronan Swords, Brian Druker, Mona Stefanos, Shelley Orwick, Tara L. Lin, Robert L. Redner, Molly Martycz, Joshua F. Zeidner, Bhavana Bhatnagar, Maria R. Baer, Timothy L. Chen, Ashley O. Yocum, Franchesca Druggan, Mitch A. Phelps, John C. Byrd, Eric D. Eisenmann, Sharyn D. Baker, Amy Burd, Ying Huang, Yazan F. Madanat, Nicole Abbott, Tibor Kovacsovics
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Supplementary Table S1 from A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant <i>TP53</i> and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years — Zeina Al‐Mansour, Uma Borate, et al. · (2025) | TGRS Research Map | TGRS